Brown Rudnick’s Global Life Sciences Group to host event on “The Mega Mergers and their Impact on Consolidation and IPOs” in the industry
On 12 November 2014, Brown Rudnick's Global Life Sciences Group will host a panel discussion entitled "Life Sciences: The Mega Mergers and their Impact on Consolidation and IPOs" in our London office. Our panel will be moderated by Sophie McGrath, a Life Sciences and Corporate partner in London, and will feature the following leaders from the life sciences industry:
- Dr Lucinda Crabtree, Panmure Gordon & Co.
- Dr Tara Dalton, Stokes Institute, University of Limerick
- Dr Martin Edwards, Novo
- Nooman Haque, Silicon Valley Bank
- Dr Jonathan Hepple, Rosetta Capital Limited
Following the discussion will be a drink and canapé networking reception. For more information on this event, please contact Kristin Fischer.